Adria Tyndall
Director, Regulatory CMC at Novartis
- Role
- Director, Regulatory Affairs Cmc at Novartis
- Location
- Chicago, IL, US
- LinkedIn followers
- 500 followers
About Adria Tyndall
Regulatory Scientist experienced in pharmaceutical regulatory strategy, intelligence and…
Experience
Director, Regulatory Affairs Cmc
Jun 2019 — Present
Regulatory CMC lead for Commercial Gene Therapy (Zolgensma) at Novartis Gene Therapies (formerly AveXis). Within Novartis, supported additional Cell and Gene therapy programs through contract manufacturing initiatives and network transformations.
Education
The Johns Hopkins University
Master of Science - MS, Regulatory Science
2013 — 2017
University of Minnesota
Bachelor of Science (B.S.), Chemistry
1998 — 2003
Skills
- Hplc
- Validation
- Gas Chromatography
- Uv/Vis
- Ftir
- Dissolution
- Sop
- Fda
- Titration
- Lifesciences
- Karl Fischer
- Ion Chromatography
- Empower
- Analytical Method Validation
- Technical Writing
- Method Transfer
- Data Review
- Change Control
- Capa
- Gmp
- Instrumentation
- Pharmaceutical Industry
- Regulatory Affairs
- Uv
- Analytical Chemistry
- Dionex
- Assay Development
- Laboratory
- Quality Control
- R&D
- Raw Materials
- Chromatography
- Quality Auditing
- Pharmaceutics
- 21 Cfr Part 11
- Chromeleon
- Instrument Troubleshooting
- Cmc Regulatory Affairs
- Licensing
- Fda Gmp
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.